Clinical trial
Tamsulosin for Urolithiasis in the Emergency Dept
NCT00382265 · Andrew Meltzer, Other · Completed
Key facts
| NCT number | NCT00382265 |
|---|---|
| Title | Tamsulosin for Urolithiasis in the Emergency Dept |
| Official title | Study of Tamsulosin for Urolithiasis in the Emergency Department |
| Acronym | STONE |
| Lead sponsor | Andrew Meltzer, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Ureterolithiases |
| Intervention type | Drug, Other |
| Interventions | tamsulosin, Placebo |
| Enrollment | 512 |
| Start date | Jan 1, 2008 |
| Primary completion | Feb 1, 2017 |
| Completion | Feb 1, 2017 |
| First posted | Sep 29, 2006 |
| Last update posted | Dec 10, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: